Filing Overview
ADC Therapeutics SA filed a Form 6-K on November 10, 2020, covering the month of November 2020. The filing identifies Exhibit 99.1 as a press release dated November 10, 2020, but the press release text is not included in the provided filing content.
Financial and Operating Information
The provided text does not contain revenue, profit or loss, cash flow, margins, debt, liquidity, clinical, or other operating metrics.
Changes Versus Prior Period
The filing text does not provide information sufficient to assess changes versus a prior comparable period.
Guidance, Outlook, Risks, and Unusual Items
The filing text does not provide guidance, outlook, management commentary, risk disclosures, contingencies, or unusual items. These matters may be addressed in the referenced Exhibit 99.1, which was not included in the source content.
Investor Verification Items
- Obtain and review Exhibit 99.1, the November 10, 2020 press release.
- Verify whether the press release contains financial results, clinical updates, financing activity, guidance, or material risk disclosures.
- Confirm any metrics or events reported in the press release against subsequent filings and the company’s Form 20-F.